Regeneron Pharmaceuticals Inc said a combination therapy containing its flagship eye drug, Eylea (aflibercept), was inferior to Eylea alone in a mid-stage trial involving patients with wet age-related macular degeneration (AMD), a leading cause of blin…
Author: Medscape
Topol on Physician and Patient Attitudes Toward New Technology
Eric Topol discusses results of a new Medscape survey assessing attitudes among both patients and physicians toward new technologies in medicine. Medscape
CDC More Cautious on Conception, Sex After Zika Exposure
Men who’ve possibly been exposed to the virus without developing symptoms should wait much longer than previously advised to attempt pregnancy with a partner or have condomless sex. News Alerts
Ranibizumab Effective for Pigment Epithelial Detachment
Low-dose ranibizumab is effective in treating pigment epithelial detachment in patients with neovascular age-related macular degeneration, a post hoc analysis of the HARBOR study suggests. Medscape Medical News
On-Site, Telemedicine Views on Infants’ Eyes May Differ
Evaluating acute-phase retinopathy of prematurity (ROP) by direct clinical examination may produce different results from evaluations done via telemedicine, according to new findings. Reuters Health Information
Two New Corneal Inlays Increase Options for Presbyopia
Dr Roger Steinert discusses the relative merits of both the KAMRA Inlay and the Raindrop Near Vision Inlay. Medscape Ophthalmology
Are Oral Bisphosphonates Associated With Wet AMD?
With the rising prevalence of oral bisphosphonate use and wet age-related macular degeneration, we must ask ourselves if the two are related. Medscape Ophthalmology
Diabetic Macular Edema: Dexamethasone Implant May Improve Vision
A dexamethasone implant improved best-corrected visual acuity and the physiological morphology of the outer retinal layers in a case series of patients with recalcitrant diabetic macular edema. Medscape Medical News
Financial Incentives Deter Attendance for Diabetic Eye Screening
Contrary to what might be expected, a financial incentive to boost uptake of diabetic retinopathy screening was found to deter invitees from attending. Medscape Medical News
Make Eye Health a National Health Priority, Report Says
National Academies report outlines roadmap to transform vision impairments from “exceedingly common to a rare condition.”
Medscape Medical News
Ancillary Techniques in Management of Microbial Keratitis
This review takes a look at the current modalities as well as new treatment techniques used to manage microbial keratitis. The British Journal of Ophthalmology
Adalimumab Effective for Treatment of Noninfectious Uveitis
Adalimumab was effective and relatively safe for acute and maintenance therapy for patients with noninfectious uveitis, a new study found. Medscape Medical News
‘One-Stop Shop’ for Diabetic Neuropathy Along With Eye Screening
While diabetic patients are waiting for their eye drops to take effect at retinopathy screening, they could quickly be assessed for early diabetic neuropathy with new devices, at a one-stop shop. Medscape Medical News
FDA Approves VisuMax Femtosecond Laser to Treat Myopia
The laser is used in small-incision lenticule extraction to reshape the cornea and reduce or eliminate nearsightedness. FDA Approvals
Predicting Anti-VEGF Response in Diabetic Macular Edema
Response after 12 weeks of ranibizumab therapy can predict long-term outcomes in diabetic macular edema, a post hoc analysis suggests. Medscape Medical News
First Response to Anti-VEGF Predicts Macular Edema Outcome
In branch retinal vein occlusion secondary to macular edema, assessment a month after the first anti-VEGF treatment predicts long-term outcome better than baseline testing, a case series shows. Medscape Medical News
Fewer Visits for Aflibercept Injection With Observe and Plan
For patients with neovascular age-related macular degeneration, ‘observe-and-plan’ leads to fewer visits for anti-VEGF injections and a more efficient use of clinic resources, 2-year data show. Medscape Medical News
Is Anti-VEGF Monotherapy Best for Diabetic Macular Edema?
One of the predictors of visual improvement in patients with diabetic macular edema is ranibizumab monotherapy, an analysis of the RESTORE data shows, but not everyone agrees with the findings. Medscape Medical News
New MACRA Rules Make Medicare Pay Cut in 2019 Less Likely
Physicians can pick their own pace of implementation in 2017 to avoid a penalty, CMS acting administrator Andy Slavitt promised today. Medscape Medical News
A Cloudy and Painful Eye
A 30-year-old man with keratoconus has sudden eye pain with light sensitivity. What is his diagnosis? Medscape Optometry